Literature DB >> 9278759

Combined-modality therapy for squamous carcinoma of the buccal mucosa: treatment results and prognostic factors.

F M Fang1, S W Leung, C C Huang, Y T Liu, C J Wang, H C Chen, L M Sun, D T Huang.   

Abstract

BACKGROUND: Reports on locoregional control and survival of squamous cell carcinoma of buccal mucosa are scarce in literature. In this study, a single institutions's experience of combined surgery and postoperative radiotherapy (RT) for buccal mucosal malignancy with favorable results was analyzed and presented. The prognostic factors on locoregional control were also discussed.
METHODS: From January 1988 to July 1994, 57 patients with squamous cell carcinoma of buccal mucosa treated by surgery and RT were reviewed. The distributions according to American Joint Committee on Cancer (AJCC) staging were: stage II, 6; stage III, 21; and stage IV, 30 patients. Total dose of RT at the buccal area ranged from 45 Gy to 68.4 Gy, median 61.2 Gy. Tumor-related factors (AJCC stage, T stage, histologic grading, pathologic tumor invasion to skin of cheek, adjacent bony structures, and regional lymph nodes) and treatment-related factors (surgical margin, radiation dose, and the time interval between operation and RT) were analyzed to determine their influence on locoregional control.
RESULTS: Three-year actuarial locoregional control rate, overall survival rate, and disease-specific survival rates were 64%, 55%, and 62%, respectively. Ten of these 22 patients (45%) with recurrent tumors were reoperated, but only 2 patients were successfully salvaged. Positive surgical margin and tumor invasion to skin of cheek were significantly poor prognostic factors on locoregional control by univariate analysis. In multivariate analysis, tumor invasion to skin of cheek was the only prognostic factor (p = .0014).
CONCLUSIONS: Locoregional failure was the major cause of death for squamous buccal mucosa cancers managed with surgery and RT. Few recurrences could be detected early and successfully salvaged. Skin of cheek involvement is an important prognostic factor for buccal mucosa cancers.

Entities:  

Mesh:

Year:  1997        PMID: 9278759     DOI: 10.1002/(sici)1097-0347(199709)19:6<506::aid-hed8>3.0.co;2-2

Source DB:  PubMed          Journal:  Head Neck        ISSN: 1043-3074            Impact factor:   3.147


  10 in total

1.  Clinicopathologic Determinants of Outcome in Pathologic T4a (pT4a) Squamous Cell Carcinoma of the Gingivobuccal Subsite of the Oral Cavity.

Authors:  Prateek V Jain; Rajeev Sharan; Kapila Manikantan; Indranil Mallick; Sanjoy Chatterjee; Indu Arun; Pattatheyil Arun
Journal:  Indian J Surg Oncol       Date:  2019-06-27

2.  Quality of life for head and neck cancer patients treated by combined modality therapy: the therapeutic benefit of technological advances in radiotherapy.

Authors:  Tai-Lin Huang; Wen-Ling Tsai; Chih-Yen Chien; Tsair-Fwu Lee; Fu-Min Fang
Journal:  Qual Life Res       Date:  2010-06-11       Impact factor: 4.147

Review 3.  Distant metastasis from oral cavity-correlation between histopathology results and primary site.

Authors:  Yuka Uchiyama; Tadashi Sasai; Atsutoshi Nakatani; Hiroaki Shimamoto; Tomomi Tsujimoto; Sven Kreiborg; Shumei Murakami
Journal:  Oral Radiol       Date:  2020-05-28       Impact factor: 1.852

4.  Buccal mucosa carcinoma: surgical margin less than 3 mm, not 5 mm, predicts locoregional recurrence.

Authors:  Wen-Yen Chiou; Hon-Yi Lin; Feng-Chun Hsu; Moon-Sing Lee; Hsu-Chueh Ho; Yu-Chieh Su; Ching-Chih Lee; Chen-Hsi Hsieh; Yao-Ching Wang; Shih-Kai Hung
Journal:  Radiat Oncol       Date:  2010-09-15       Impact factor: 3.481

5.  Epidemiological Features and Management of Oral Cancer Patients: Experience from a Single Private Comprehensive Cancer Care Center in the State of Odisha.

Authors:  Sanjoy Panda; Bibhuti Bishnu Nayak; N M L Manjunath; Krupasindhu Panda; Pramod Chandra Pathi
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2018-03-26

6.  Squamous cell carcinoma of the buccal mucosa: Analysis of clinical presentation, outcome and prognostic factors.

Authors:  Qi-Gen Fang; Shuang Shi; Zhen-Ning Li; Xu Zhang; Fa-Yu Liua; Zhong-Fei Xu; Chang-Fu Sun
Journal:  Mol Clin Oncol       Date:  2013-03-05

7.  Health-related quality of life in 640 head and neck cancer survivors after radiotherapy using EORTC QLQ-C30 and QLQ-H&N35 questionnaires.

Authors:  Stephen Wan Leung; Tsair-Fwu Lee; Chih-Yen Chien; Pei-Ju Chao; Wen-Ling Tsai; Fu-Min Fang
Journal:  BMC Cancer       Date:  2011-04-12       Impact factor: 4.430

8.  IMRT in oral cavity cancer.

Authors:  Gabriela Studer; Roger A Zwahlen; Klaus W Graetz; Bernard J Davis; Christoph Glanzmann
Journal:  Radiat Oncol       Date:  2007-04-12       Impact factor: 3.481

9.  Nomogram predicting long-term overall and cancer-specific survival of patients with buccal mucosa cancer.

Authors:  Fengze Wang; Jiao Wen; Shuaishuai Cao; Xinjie Yang; Zihui Yang; Huan Li; Haifeng Meng; Florian M Thieringer; Jianhua Wei
Journal:  BMC Oral Health       Date:  2022-04-22       Impact factor: 2.757

10.  Prognostic factors and related complications/sequalae of squamous cell carcinoma located in the gingivobuccal complex.

Authors:  Yunhao Zhu; Bo Li; Huan Liu; Delong Li; Aoming Cheng; Chong Wang; Zhengxue Han; Zhien Feng
Journal:  World J Surg Oncol       Date:  2022-07-26       Impact factor: 3.253

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.